OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019
Nikolaos Tziolos, Emmanouil Karofylakis, Ioannis Grigoropoulos, et al.
Open Forum Infectious Diseases (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Nikolaos Tziolos, Emmanouil Karofylakis, Ioannis Grigoropoulos, et al.
Open Forum Infectious Diseases (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Showing 9 citing articles:
NLRP3 Inflammasomes: Dual Function in Infectious Diseases
Yanbo Li, Rui Qiang, Zheng-Min Cao, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 4, pp. 407-417
Closed Access | Times Cited: 7
Yanbo Li, Rui Qiang, Zheng-Min Cao, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 4, pp. 407-417
Closed Access | Times Cited: 7
Pharmaceutical Perspectives on Oligonucleotide Therapeutics and Delivery Systems
Dalton W. Staller, Flobater I. Gawargi, Sanjali S. Panigrahi, et al.
Pharmacological Reviews (2025), pp. 100065-100065
Closed Access
Dalton W. Staller, Flobater I. Gawargi, Sanjali S. Panigrahi, et al.
Pharmacological Reviews (2025), pp. 100065-100065
Closed Access
Inhibition of the JAK/STAT Pathway With Baricitinib Reduces the Multiple Organ Dysfunction Caused by Hemorrhagic Shock in Rats
Nikita M. Patel, Debora Collotta, Eleonora Aimaretti, et al.
Annals of Surgery (2022) Vol. 278, Iss. 1, pp. e137-e146
Open Access | Times Cited: 15
Nikita M. Patel, Debora Collotta, Eleonora Aimaretti, et al.
Annals of Surgery (2022) Vol. 278, Iss. 1, pp. e137-e146
Open Access | Times Cited: 15
Insights into CD24 and Exosome Physiology and Potential Role in View of Recent Advances in COVID-19 Therapeutics: A Narrative Review
Georgios Tsioulos, Ioannis Grigoropoulos, Charalampos D. Moschopoulos, et al.
Life (2022) Vol. 12, Iss. 10, pp. 1472-1472
Open Access | Times Cited: 7
Georgios Tsioulos, Ioannis Grigoropoulos, Charalampos D. Moschopoulos, et al.
Life (2022) Vol. 12, Iss. 10, pp. 1472-1472
Open Access | Times Cited: 7
A review of clinical efficacy data supporting emergency use authorization for COVID ‐19 therapeutics and lessons for future pandemics
Seo‐Hyun Yoo, Lauren Kim, Michelle Lu, et al.
Clinical and Translational Science (2022) Vol. 15, Iss. 10, pp. 2279-2292
Open Access | Times Cited: 6
Seo‐Hyun Yoo, Lauren Kim, Michelle Lu, et al.
Clinical and Translational Science (2022) Vol. 15, Iss. 10, pp. 2279-2292
Open Access | Times Cited: 6
JAK-STAT signaling as an ARDS therapeutic target: Status and future trends
Yuanteng Zhang, Zizheng Gao, Feng Jiang, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115382-115382
Open Access | Times Cited: 6
Yuanteng Zhang, Zizheng Gao, Feng Jiang, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115382-115382
Open Access | Times Cited: 6
Inhibition of the JAK/STAT pathway with baricitinib reduces the multiple organ dysfunction caused by hemorrhagic shock in rats
Nikita M. Patel, Debora Collotta, Eleonora Aimaretti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Nikita M. Patel, Debora Collotta, Eleonora Aimaretti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Janus kinases inhibitors for coronavirus disease-2019: A pairwise and Bayesian network meta-analysis
Jianyi Niu, Zhiwei Lin, Zhenfeng He, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 1
Jianyi Niu, Zhiwei Lin, Zhenfeng He, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 1
Baricitinib in the Treatment of COVID-19
Shubham Atal, Ananyan Sampath, Aditya Banerjee, et al.
IntechOpen eBooks (2022)
Open Access
Shubham Atal, Ananyan Sampath, Aditya Banerjee, et al.
IntechOpen eBooks (2022)
Open Access
Survival Benefit of High Dose Versus Usual Dose of Baricitinib in Hospitalized Patients with COVID-19: A Systematic Review
Shihan Mahmud Redwanul Huq, Raziuddin Ahmed, Mahiuddin Ahmed, et al.
Medical Research Archives (2022) Vol. 10, Iss. 9
Open Access
Shihan Mahmud Redwanul Huq, Raziuddin Ahmed, Mahiuddin Ahmed, et al.
Medical Research Archives (2022) Vol. 10, Iss. 9
Open Access
